Return of results in translational iPS cell research: Considerations for donor informed consent

Stem Cell Research and Therapy

Volumn 4, Issue 1, 2013, Pages

  Lomax, Geoffrey P ^a   Shepard, Kelly A ^a  

^a not available   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERIVATIZATION; DISEASE MODEL; GENE SEQUENCE; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; INFORMED CONSENT; MEDICAL SERVICE; PLURIPOTENT STEM CELL; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; THERAPEUTIC MISCONCEPTION; TRANSLATIONAL RESEARCH; CELL LINE; DONOR; MENTAL CAPACITY; PHYSIOLOGY; PROCEDURES;

CELL LINE; HUMANS; INDUCED PLURIPOTENT STEM CELLS; INFORMED CONSENT; MENTAL COMPETENCY; TISSUE DONORS; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84872692308     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt154     Document Type: Review

References (23)

1. Human disease modeling with induced pluripotent stem cells. Trounson A, Shepard KA, Dewitt ND, Curr Opin Genet Dev 2012 22 509 516 10.1016/j.gde.2012. 07.004 22868174
2. Specimen collection for induced pluripotent stem cell research: harmonizing the approach to informed consent. Lowenthal J, Lipnick S, Rao M, Hull S, Stem Cells Transl Med 2012 1 409 421 10.5966/sctm.2012-0029 23197820
3. RFA 12-04: CIRM hPSC Repository Award. http://www.cirm.ca.gov/RFA/rfa-12- 04-cirm-hpsc-repository-award
4. Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Crock BN, Van Ness B, Lawrenz F, Kahn JP, Beskow LM, Cho MK, Christman MF, Green RC, Hall R, Illes J, Keane M, Knoppers BM, Koenig BA, Kohane IS, Leroy B, Maschke KJ, McGeveran W, Ossorio P, Parker LS, Petersen GM, Richardson HS, Scott JA, Terry SF, Wilfond BS, Wolf WA, Genet Med 2012 14 361 384 10.1038/gim.2012.23 22436882
5. Ethical and practical guidelines for reporting genetic research results to study participants: updated guidelines from a National Heart, Lung, and Blood Institute working group. Fabsitz RR, McGuire A, Sharp RR, Puggal M, Beskow LM, Biesecker LG, Bookman E, Burke W, Burchard EG, Church G, Clayton EW, Eckfeldt JH, Fernandez CV, Fisher R, Fullerton SM, Gabriel S, Gachupin F, James C, Jarvik GP, Kittles R, O'Donnell C, O'Rourke P P, Rodriguez LL, Schully SD, Shuldiner AR, Sze RK, Thakuria JV, Wolf SM, Burke GL, Circ Cardiovasc Genet 2010 3 574 580 10.1161/CIRCGENETICS.110.958827 21156933
6. An empirical examination of the management of return of individual research results and incidental findings in genomic biobanks. Johnson G, Lawrenz F, Thao M, Genet Med 2012 14 444 450 10.1038/gim.2012.20 22361899
7. National Bioethics Advisory Comission, Research Involving Human Biological Materials: Ethical Issues and Policy Guidance: Volume 1 Bethesda, MD: National Bioethics Advisory Commission 1999 http://bioethics.georgetown.edu/ nbac/pubs.html (accessed 11/14/12)
8. Exploring concordance and discordance for return of incidental findings from clinical sequencing. Green RC, Berg JS, Berry GT, Biesecker LG, Dimmock DP, Evans J P, Grody WW, Hegde MR, Kalia S, Korf BR, Krantz I, McGuire AL, Miller DT, Murray MF, Nussbaum RL, Plon SE, Rehm HL, Jacob HJ, Genet Med 2012 14 405 410 10.1038/gim.2012.21 22422049
9. The California Stem Cell Research and Cures Initiative 2004 (Proposition 71). http://www.cirm.ca.gov/files/PDFs/Administrative/prop71-3.pdf (accessed 11/14/12)
10. Background mutations in parental cells account for most of the genetic heterogeneity of induced pluripotent stem cells. Young MA, Larson DE, Sun CW, George DR, Ding L, Miller CA, Lin L, Pawlik KM, Chen K, Fan X, Schmidt H, Kalicki-Veizer J, Cook LL, Swift GW, Demeter RT, Wendl MC, Sands MS, Mardis ER, Wilson RK, Townes TM, Ley TJ, Cell Stem Cell 2012 10 570 582 10.1016/j.stem.2012.03.002 22542160
11. Somatic coding mutations in human induced pluripotent stem cells. Gore A, Li Z, Fung HL, Young JE, Agarwal S, Antosiewicz-Bourget J, Canto I, Giorgetti A, Israel MA, Kiskinis E, Lee JH, Loh YH, Manos PD, Montserrat N, Panopoulos AD, Ruiz S, Wilbert ML, Yu J, Kirkness EF, Izpisua Belmonte JC, Rossi DJ, Thomson JA, Eggan K, Daley GQ, Goldstein LS, Zhang K, Nature 2011 471 63 67 10.1038/nature09805 21368825
12. Dynamic changes in the copy number of pluripotency and cell proliferation genes in human ESCs and iPSCs during reprogramming and time in culture. Laurent LC, Ulitsky I, Slavin I, Tran H, Schork A, Morey R, Lynch C, Harness JV, Lee S, Barrero MJ, Ku S, Martynova M, Semechkin R, Galat V, Gottesfeld J, Izpisua Belmonte JC, Murry C, Keirstead HS, Park HS, Schmidt U, Laslett AL, Muller FJ, Nievergelt CM, Shamir R, Loring JF, Cell Stem Cell 2011 8 106 118 10.1016/j.stem.2010.12.003 21211785
13. Transcriptional signature and memory retention of human-induced pluripotent stem cells. Marchetto MC, Yeo GW, Kainohana O, Marsala M, Gage FH, Muotri AR, PLoS One 2009 4 7076 10.1371/journal.pone.0007076 19763270
14. Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Ohi Y, Qin H, Hong C, Blouin L, Polo JM, Guo T, Qi Z, Downey SL, Manos PD, Rossi DJ, Yu J, Hebrok M, Hochedlinger K, Costello JF, Song JS, Ramalho-Santos M, Nat Cell Biol 2011 13 541 549 10.1038/ncb2239 21499256
15. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells. Lister R, Pelizzola M, Kida YS, Hawkins RD, Nery JR, Hon G, Antosiewicz- Bourget J, O'Malley R, Castanon R, Klugman S, Downes M, Yu R, Stewart R, Ren B, Thomson JA, Evans RM, Ecker JR, Nature 2011 471 68 73 10.1038/nature09798 21289626
16. Erosion of dosage compensation impacts human iPSC disease modeling. Mekhoubad S, Bock C, de Boer A S, Kiskinis E, Meissner A, Eggan K, Cell Stem Cell 2012 10 595 609 10.1016/j.stem.2012.02.014 22560080
17. Recurrent variations in DNA methylation in human pluripotent stem cells and their diff erentiated derivatives. Nazor KL, Altun G, Lynch C, Tran H, Harness JV, Slavin I, Garitaonandia I, Muller FJ, Wang YC, Boscolo FS, Fakunle E, Dumevska B, Lee S, Park HS, Olee T, D'Lima DD, Semechkin R, Parast MM, Galat V, Laslett AL, Schmidt U, Keirstead HS, Loring JF, Laurent LC, Cell Stem Cell 2012 10 620 634 10.1016/j.stem.2012.02.013 22560082
18. Reporting genetic results in research studies: summary and recommendations of an NHLBI working group. Bookman EB, Langehorne AA, Eckfeldt JH, Glass KC, Jarvik GP, Klag M, Koski G, Motulsky A, Wilfond B, Manolio TA, Fabsitz RR, Luepker RV, Am J Med Genet A 2006 140 1033 1040 16575896
19. Return of results: not that complicated? Evans JP, Rothschild BB, Genet Med 2012 14 358 360 10.1038/gim.2012.8 22481183
20. Scientific and Medical Accountablity Standards Working Group Regular Meeting. http://www.cirm.ca.gov/files/transcripts/pdf/2012/040612-transcript.pdf
21. The legal risks of returning results of genomics research. Clayton EW, McGuire AL, Genet Med 2012 14 473 477 10.1038/gim.2012.10 22323070
22. Practical implementation issues and challenges for biobanks in the return of individual research results. Bledsoe MJ, Grizzle WE, Clark BJ, Zeps N, Genet Med 2012 14 478 483 10.1038/gim.2011.67 22323073
23. Public preferences regarding the return of individual genetic research results: findings from a qualitative focus group study. Bollinger JM, Scott J, Dvoskin R, Kaufman D, Genet Med 2012 14 451 457 10.1038/gim.2011.66 22402755